The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment.

PROMs are relevant in HTA for RDTs but pose a number of difficulties. A deeper understanding of the potential advantages of and the challenges and potential solutions for each can help manage these difficulties.